Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report

por Bearz, Alessandra, Santarossa, Sandra, Manfrè, Antonio, Beltrame, Giorgio, Urbani, Martina, Sartor, Ivana, Da Ros, Valentina, Tirelli, Umberto
Publicado 2014

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation

por Bearz, Alessandra, De Carlo, Elisa, Del Conte, Alessandro, Spina, Michele, Da Ros, Valentina, Bertoli, Elisa, Revelant, Alberto, Stanzione, Brigida, Tirelli, Umberto
Publicado 2022

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience

por De Carlo, Elisa, Del Savio, Maria Chiara, Polesel, Jerry, Da Ros, Valentina, Berto, Eleonora, Santarossa, Sandra, Chimienti, Emanuela, Fratino, Lucia, Bearz, Alessandra
Publicado 2018

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

por De Carlo, Elisa, Schiappacassi, Monica, Urbani, Martina, Doliana, Roberto, Baldassarre, Gustavo, Da Ros, Valentina, Santarossa, Sandra, Chimienti, Emanuela, Berto, Eleonora, Fratino, Lucia, Bearz, Alessandra
Publicado 2018

First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

por Lorenzi, Martina, Ferro, Alessandra, Cecere, Fabiana, Scattolin, Daniela, Del Conte, Alessandro, Follador, Alessandro, Pilotto, Sara, Polo, Valentina, Santarpia, Mariacarmela, Chiari, Rita, Pavan, Alberto, Dal Maso, Alessandro, Da Ros, Valentina, Targato, Giada, Vari, Sabrina, Indraccolo, Stefano, Calabrese, Fiorella, Frega, Stefano, Bonanno, Laura, Conte, Pier Franco, Guarneri, Valentina, Pasello, Giulia
Publicado 2021